Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 3
116
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Expression analysis of inflammatory response-associated genes in coronary artery disease

, , , ORCID Icon &
Pages 601-607 | Received 05 Nov 2019, Accepted 18 Dec 2019, Published online: 08 Jan 2020

References

  • Bentzon, J.F., et al., 2014. Mechanisms of plaque formation and rupture. Circulation research, 114 (12), 1852–1866.
  • Cho, H., et al., 2019. Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes. Journal of biological chemistry, 294 (11), 3881–3898.
  • Clearfield, M.B., 2005. C-reactive protein: a new risk assessment tool for cardiovascular disease. The journal of the American osteopathic association, 105 (9), 409–416.
  • Congrains, A., et al., 2013. ANRIL: molecular mechanisms and implications in human health. International journal of molecular sciences, 14 (1), 1278–1292.
  • Conti, P. and Shaik-Dasthagirisaeb, Y., 2015. Atherosclerosis: a chronic inflammatory disease mediated by mast cells. Central European journal of immunology, 40, 380.
  • Dewald, O., et al., 2004. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. The American journal of pathology, 164 (2), 665–677.
  • Ebadi, N., et al., 2019a. Expression analysis of CEBPA and its antisense RNA revealed their dysregulation in peripheral blood of coronary artery disease patients. Gene reports, 16, p.100466.
  • Ebadi, N., et al., 2019b. Dysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients. European journal of pharmacology, 867, 172852.
  • Galkina, E. and Ley, K., 2009. Immune and inflammatory mechanisms of atherosclerosis. Annual review of immunology, 27, 165–197.
  • Gutiérrez, E., et al., 2013. Endothelial dysfunction over the course of coronary artery disease. European heart journal, 34, 3175–3181.
  • Hasdai, D., et al., 1996. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart, 76 (1), 24–28.
  • Helgadottir, A., et al., 2007. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science, 316 (5830), 1491–1493.
  • Holdt, L.M., et al., 2010. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arteriosclerosis, thrombosis, and vascular biology, 30 (3), 620–627.
  • Jarinova, O., et al., 2009. Functional analysis of the chromosome 9p21. 3 coronary artery disease risk locus. Arteriosclerosis, thrombosis, and vascular biology, 29 (10), 1671–1677.
  • Libby, P., et al., 2019. Atherosclerosis. Nature reviews. Disease primers, 5 (1), 56.
  • Liu, B., et al., 2015. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis . Cancer cell, 27 (3), 370–381.
  • Liu, T., et al., 2017. NF-κB signaling in inflammation. Signal transduction and targeted therapy, 2 (1), 17023.
  • Liu, Y., et al., 2009. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLOS one, 4 (4), e5027.
  • Mcpherson, R., et al., 2007. A common allele on chromosome 9 associated with coronary heart disease. Science, 316 (5830), 1488–1491.
  • World Health Organization. 2017. Cardiovascular diseases (CVDs). Available from: https://www.who.int/cardiovascular_diseases/en/.
  • Qian, X., Shi, S., and Zhang, G., 2019. Long non-coding RNA antisense non-coding RNA in the INK4 locus expression correlates with increased disease risk, severity, and inflammation of allergic rhinitis. Medicine (Baltimore). 98, e15247.
  • Rahimi, E., et al., 2018. Association of ANRIL expression with coronary artery disease in Type 2 diabetic patients. Cell journal, 20 (1), 41–45.
  • Ramji, D.P. and Davies, T.S., 2015. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine and growth factor reviews, 26, 673–685.
  • Rial, N.S., et al., 2012. Nuclear factor kappa B (NF-kappaB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion? Medical hypotheses, 78 (1), 29–32.
  • Szekely, Y. and Arbel, Y., 2018. A review of interleukin-1 in heart disease: where do we stand today? Cardiology and therapy, 7 (1), 25–44.
  • Tabas, I. and Lichtman, A.H., 2017. Monocyte-macrophages and T cells in atherosclerosis. Immunity, 47 (4), 621–634.
  • Yari, M., et al., 2018. Association between long noncoding RNA ANRIL expression variants and susceptibility to coronary artery disease. International journal of molecular and cellular medicine, 7 (1), 1–7.
  • Yazdani, M.R., Khosropanah, S., and Doroudchi, M., 2019. Interleukin-17 production by CD4 + CD45RO + Foxp3+ T cells in peripheral blood of patients with atherosclerosis. Archives of medical sciences. Atherosclerotic diseases, 4, e215–e224.
  • Zhou, X., et al., 2016. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway. RNA biology, 13 (1), 98–108.
  • Zhu, X., et al., 2019. LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop. Journal of molecular and cellular cardiology, 126, 60–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.